T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment

Zou, 2005, Immunosuppressive networks in the tumour environment and their therapeutic relevance, Nat Rev Cancer, 5, 263, 10.1038/nrc1586 Vanneman, 2012, Combining immunotherapy and targeted therapies in cancer treatment, Nat Rev Cancer, 12, 237, 10.1038/nrc3237 Pardoll, 2012, The blockade of immune checkpoints in cancer immunotherapy, Nat Rev Cancer, 12, 252, 10.1038/nrc3239 Schwartz, 1990, A cell culture model for T lymphocyte clonal anergy, Science, 248, 1349, 10.1126/science.2113314 Schwartz, 2003, T cell anergy, Annu Rev Immunol, 21, 305, 10.1146/annurev.immunol.21.120601.141110 Wells, 2009, New insights into the molecular basis of T cell anergy: anergy factors, avoidance sensors, and epigenetic imprinting, J Immunol, 182, 7331, 10.4049/jimmunol.0803917 Zou, 2008, Inhibitory B7-family molecules in the tumour microenvironment, Nat Rev Immunol, 8, 467, 10.1038/nri2326 Blank, 2004, PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells, Cancer Res, 64, 1140, 10.1158/0008-5472.CAN-03-3259 Curiel, 2003, Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity, Nat Med, 9, 562, 10.1038/nm863 Kryczek, 2006, B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma, J Exp Med, 203, 871, 10.1084/jem.20050930 Chen, 1992, Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4, Cell, 71, 1093, 10.1016/S0092-8674(05)80059-5 Gajewski, 1996, B7-1 but not B7-2 efficiently costimulates CD8+ T lymphocytes in the P815 tumor system in vitro, J Immunol, 156, 465, 10.4049/jimmunol.156.2.465 Blank, 2006, Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro, Int J Cancer, 119, 317, 10.1002/ijc.21775 Brown, 2006, Homeostatic proliferation as an isolated variable reverses CD8+ T cell anergy and promotes tumor rejection, J Immunol, 177, 4521, 10.4049/jimmunol.177.7.4521 Nazareth, 2007, Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells, J Immunol, 178, 5552, 10.4049/jimmunol.178.9.5552 Broderick, 2006, IL-12 reverses anergy to T cell receptor triggering in human lung tumor-associated memory T cells, Clin Immunol, 118, 159, 10.1016/j.clim.2005.09.008 Greenwald, 2001, CTLA-4 regulates induction of anergy in vivo, Immunity, 14, 145, 10.1016/S1074-7613(01)00097-8 Zheng, 2012, Transcriptional regulator early growth response gene 2 (Egr2) is required for T cell anergy in vitro and in vivo, J Exp Med, 10.1084/jem.20120342 Boussiotis, 1997, Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1, Science, 278, 124, 10.1126/science.278.5335.124 Dolmetsch, 1998, Calcium oscillations increase the efficiency and specificity of gene expression, Nature, 392, 933, 10.1038/31960 Anandasabapathy, 2003, GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells, Immunity, 18, 535, 10.1016/S1074-7613(03)00084-0 Soto-Nieves, 2009, Transcriptional complexes formed by NFAT dimers regulate the induction of T cell tolerance, J Exp Med, 206, 867, 10.1084/jem.20082731 Jeon, 2004, Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction, Immunity, 21, 167, 10.1016/j.immuni.2004.07.013 Mueller, 2004, E3 ubiquitin ligases as T cell anergy factors, Nat Immunol, 5, 883, 10.1038/ni1106 Thomas, 2007, Ikaros enforces the costimulatory requirement for IL2 gene expression and is required for anergy induction in CD4+ T lymphocytes, J Immunol, 179, 7305, 10.4049/jimmunol.179.11.7305 Gao, 2012, Analysis of sirtuin 1 expression reveals a molecular explanation of IL-2-mediated reversal of T-cell tolerance, Proc Natl Acad Sci U S A, 109, 899, 10.1073/pnas.1118462109 Bandyopadhyay, 2007, Interleukin 2 gene transcription is regulated by Ikaros-induced changes in histone acetylation in anergic T cells, Blood, 109, 2878, 10.1182/blood-2006-07-037754 Wherry, 2011, T cell exhaustion, Nat Immunol, 12, 492, 10.1038/ni.2035 Barber, 2006, Restoring function in exhausted CD8 T cells during chronic viral infection, Nature, 439, 682, 10.1038/nature04444 Wu, 2009, Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions, Cancer Res, 69, 8067, 10.1158/0008-5472.CAN-09-0901 Baitsch, 2011, Exhaustion of tumor-specific CD8(+) T cells in metastases from melanoma patients, J Clin Invest, 121, 2350, 10.1172/JCI46102 Brahmer, 2012, Safety and activity of anti-PD-L1 antibody in patients with advanced cancer, N Engl J Med, 10.1056/NEJMoa1200694 Topalian, 2012, Safety, activity, and immune correlates of anti-PD-1 antibody in cancer, N Engl J Med, 10.1056/NEJMoa1200690 Riley, 2009, PD-1 signaling in primary T cells, Immunol Rev, 229, 114, 10.1111/j.1600-065X.2009.00767.x Haymaker, 2012, PD-1 and BTLA and CD8(+) T-cell ‘exhaustion’ in cancer: ‘exercising’ an alternative viewpoint, Oncoimmunology, 1, 735, 10.4161/onci.20823 Goldberg, 2007, Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells, Blood, 110, 186, 10.1182/blood-2006-12-062422 Wherry, 2007, Molecular signature of CD8+ T cell exhaustion during chronic viral infection, Immunity, 27, 670, 10.1016/j.immuni.2007.09.006 Blackburn, 2009, Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection, Nat Immunol, 10, 29, 10.1038/ni.1679 Sakuishi, 2010, Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity, J Exp Med, 207, 2187, 10.1084/jem.20100643 Li, 2012, Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma, Hepatology, 56, 1342, 10.1002/hep.25777 Zhou, 2011, Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia, Blood, 117, 4501, 10.1182/blood-2010-10-310425 Fourcade, 2012, CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1, Cancer Res, 72, 887, 10.1158/0008-5472.CAN-11-2637 Derre, 2010, BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination, J Clin Invest, 120, 157, 10.1172/JCI40070 Jin, 2010, Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection, Proc Natl Acad Sci U S A, 107, 14733, 10.1073/pnas.1009731107 Woo, 2012, Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape, Cancer Res, 72, 917, 10.1158/0008-5472.CAN-11-1620 Adibzadeh, 1995, Long-term culture of monoclonal human T lymphocytes: models for immunosenescence?, Mech Ageing Dev, 83, 171, 10.1016/0047-6374(95)01625-A Effros, 1998, Replicative senescence in the immune system: impact of the Hayflick limit on T-cell function in the elderly, Am J Hum Genet, 62, 1003, 10.1086/301845 Hayflick, 1961, The serial cultivation of human diploid cell strains, Exp Cell Res, 25, 585, 10.1016/0014-4827(61)90192-6 Passos, 2010, Feedback between p21 and reactive oxygen production is necessary for cell senescence, Mol Syst Biol, 6, 347, 10.1038/msb.2010.5 Rodier, 2009, Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion, Nat Cell Biol, 11, 973, 10.1038/ncb1909 Beausejour, 2003, Reversal of human cellular senescence: roles of the p53 and p16 pathways, EMBO J, 22, 4212, 10.1093/emboj/cdg417 Appay, 2000, HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function, J Exp Med, 192, 63, 10.1084/jem.192.1.63 Akbar, 2011, Are senescence and exhaustion intertwined or unrelated processes that compromise immunity?, Nat Rev Immunol, 11, 289, 10.1038/nri2959 Pawelec, 2001, Immunoageing—the cause or effect of morbidity, Trends Immunol, 22, 348, 10.1016/S1471-4906(01)01956-1 Vallejo, 2004, T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection, Trends Mol Med, 10, 119, 10.1016/j.molmed.2004.01.002 Montes, 2008, Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion, Cancer Res, 68, 870, 10.1158/0008-5472.CAN-07-2282 Meloni, 2006, Foxp3 expressing CD4+ CD25+ and CD8+CD28− T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma, Hum Immunol, 67, 1, 10.1016/j.humimm.2005.11.005 Tsukishiro, 2003, Rapid turnover of the CD8(+)CD28(−) T-cell subset of effector cells in the circulation of patients with head and neck cancer, Cancer Immunol Immunother, 52, 599, 10.1007/s00262-003-0395-6 Van Nguyen, 2007, DNA damage-induced cellular senescence is sufficient to suppress tumorigenesis: a mouse model, J Exp Med, 204, 1453, 10.1084/jem.20062453 Brenchley, 2003, Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells, Blood, 101, 2711, 10.1182/blood-2002-07-2103 Heffner, 2007, Loss of T cell receptor-induced Bmi-1 in the KLRG1(+) senescent CD8(+) T lymphocyte, Proc Natl Acad Sci U S A, 104, 13414, 10.1073/pnas.0706040104 Voehringer, 2001, Viral infections induce abundant numbers of senescent CD8 T cells, J Immunol, 167, 4838, 10.4049/jimmunol.167.9.4838 Fourcade, 2010, Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients, J Exp Med, 207, 2175, 10.1084/jem.20100637 Huang, 2010, Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion, J Exp Med, 207, 505, 10.1084/jem.20090397 Zhu, 2005, The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity, Nat Immunol, 6, 1245, 10.1038/ni1271 Rangachari, 2012, Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion, Nat Med, 18, 1394, 10.1038/nm.2871 Fearon, 2001, Arrested differentiation, the self-renewing memory lymphocyte, and vaccination, Science, 293, 248, 10.1126/science.1062589 Lanzavecchia, 2002, Progressive differentiation and selection of the fittest in the immune response, Nat Rev Immunol, 2, 982, 10.1038/nri959 Zhang, 2005, Host-reactive CD8+ memory stem cells in graft-versus-host disease, Nat Med, 11, 1299, 10.1038/nm1326 Gattinoni, 2009, Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells, Nat Med, 15, 808, 10.1038/nm.1982 Kryczek, 2011, Human TH17 cells are long-lived effector memory cells, Sci Transl Med, 3, 104ra100, 10.1126/scitranslmed.3002949 Muranski, 2011, Th17 cells are long lived and retain a stem cell-like molecular signature, Immunity, 35, 972, 10.1016/j.immuni.2011.09.019 Wei, 2012, Th17 cells have stem cell-like features and promote long-term tumor immunity, OncoImmunology, 1 Workman, 2004, Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo, J Immunol, 172, 5450, 10.4049/jimmunol.172.9.5450 Huang, 2004, Role of LAG-3 in regulatory T cells, Immunity, 21, 503, 10.1016/j.immuni.2004.08.010 Bengsch, 2010, Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation, PLoS Pathog, 6, e1000947, 10.1371/journal.ppat.1000947